270 related articles for article (PubMed ID: 32950701)
1. The Associations of Aspirin, Statins, and Metformin With Lung Cancer Risk and Related Mortality: A Time-Dependent Analysis of Population-Based Nationally Representative Data.
Kang J; Jeong SM; Shin DW; Cho M; Cho JH; Kim J
J Thorac Oncol; 2021 Jan; 16(1):76-88. PubMed ID: 32950701
[TBL] [Abstract][Full Text] [Related]
2. Association of Aspirin, Metformin, and Statin Use with Gastric Cancer Incidence and Mortality: A Nationwide Cohort Study.
Cho MH; Yoo TG; Jeong SM; Shin DW
Cancer Prev Res (Phila); 2021 Jan; 14(1):95-104. PubMed ID: 32938643
[TBL] [Abstract][Full Text] [Related]
3. Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?
Zanders MM; van Herk-Sukel MP; Vissers PA; Herings RM; Haak HR; van de Poll-Franse LV
Br J Cancer; 2015 Jul; 113(3):403-10. PubMed ID: 26180924
[TBL] [Abstract][Full Text] [Related]
4. Population-wide impacts of aspirin, statins, and metformin use on prostate cancer incidence and mortality.
Koo HY; Jeong SM; Cho MH; Chun S; Shin DW; Park J
Sci Rep; 2021 Aug; 11(1):16171. PubMed ID: 34373584
[TBL] [Abstract][Full Text] [Related]
5. Common medications and survival in women with ovarian cancer: A systematic review and meta-analysis.
Majidi A; Na R; Dixon-Suen S; Jordan SJ; Webb PM
Gynecol Oncol; 2020 Jun; 157(3):678-685. PubMed ID: 32317171
[TBL] [Abstract][Full Text] [Related]
6. Statins dose-dependently exert a chemopreventive effect against lung cancer in COPD patients: a population-based cohort study.
Liu JC; Yang TY; Hsu YP; Hao WR; Kao PF; Sung LC; Chen CC; Wu SY
Oncotarget; 2016 Sep; 7(37):59618-59629. PubMed ID: 27517752
[TBL] [Abstract][Full Text] [Related]
7. Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study.
Löfling LL; Støer NC; Andreassen BK; Ursin G; Botteri E
Breast Cancer Res; 2023 Aug; 25(1):101. PubMed ID: 37649039
[TBL] [Abstract][Full Text] [Related]
8. Aspirin, metformin, and statin use on the risk of gastric cancer: A nationwide population-based cohort study in Korea with systematic review and meta-analysis.
Seo SI; Park CH; Kim TJ; Bang CS; Kim JY; Lee KJ; Kim J; Kim HH; You SC; Shin WG
Cancer Med; 2022 Feb; 11(4):1217-1231. PubMed ID: 34970858
[TBL] [Abstract][Full Text] [Related]
9. Aspirin, Statins, Non-aspirin NSAIDs, Metformin, and the Risk of Biliary Cancer: A Swedish Population-Based Cohort Study.
Marcano-Bonilla L; Schleck CD; Harmsen WS; Sadr-Azodi O; Borad MJ; Patel T; Petersen GM; Therneau TM; Roberts LR; Brusselaers N
Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):804-810. PubMed ID: 35086822
[TBL] [Abstract][Full Text] [Related]
10. The effect of concomitant use of statins, NSAIDs, low-dose aspirin, metformin and beta-blockers on outcomes in patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.
Zhang Y; Chen H; Chen S; Li Z; Chen J; Li W
Oncoimmunology; 2021; 10(1):1957605. PubMed ID: 34377596
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review.
Saka Herrán C; Jané-Salas E; Estrugo Devesa A; López-López J
Oral Oncol; 2018 Oct; 85():68-81. PubMed ID: 30220322
[TBL] [Abstract][Full Text] [Related]
12. The risk of prostate cancer for men on aspirin, statin or antidiabetic medications.
Nordström T; Clements M; Karlsson R; Adolfsson J; Grönberg H
Eur J Cancer; 2015 Apr; 51(6):725-33. PubMed ID: 25727881
[TBL] [Abstract][Full Text] [Related]
13. Cancer risk in HBV patients with statin and metformin use: a population-based cohort study.
Chen CI; Kuan CF; Fang YA; Liu SH; Liu JC; Wu LL; Chang CJ; Yang HC; Hwang J; Miser JS; Wu SY
Medicine (Baltimore); 2015 Feb; 94(6):e462. PubMed ID: 25674734
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study.
Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Hinkula M; Läärä E
BMC Cancer; 2018 Jul; 18(1):767. PubMed ID: 30055585
[TBL] [Abstract][Full Text] [Related]
15. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.
Tseng CH
Liver Int; 2018 Nov; 38(11):2018-2027. PubMed ID: 29956875
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
Zeng RW; Yong JN; Tan DJH; Fu CE; Lim WH; Xiao J; Chan KE; Tan C; Goh XL; Chee D; Syn N; Tan EX; Muthiah MD; Ng CH; Tamaki N; Lee SW; Kim BK; Nguyen MH; Loomba R; Huang DQ
Aliment Pharmacol Ther; 2023 Mar; 57(6):600-609. PubMed ID: 36625733
[TBL] [Abstract][Full Text] [Related]
17. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
18. Risk of Cause-Specific Death in Individuals with Cancer-Modifying Role Diabetes, Statins and Metformin.
Haukka J; Niskanen L; Auvinen A
Int J Cancer; 2017 Dec; 141(12):2437-2449. PubMed ID: 28840596
[TBL] [Abstract][Full Text] [Related]
19. Association of Long-term Use of Low-Dose Aspirin as Chemoprevention With Risk of Lung Cancer.
Ye S; Lee M; Lee D; Ha EH; Chun EM
JAMA Netw Open; 2019 Mar; 2(3):e190185. PubMed ID: 30821825
[TBL] [Abstract][Full Text] [Related]
20. Effects of Statin, Aspirin or Metformin Use on Recurrence-Free and Overall Survival in Patients with Biliary Tract Cancer.
McNamara MG; Aneja P; Le LW; Horgan AM; McKeever E; Knox JJ
Hepatogastroenterology; 2015 May; 62(139):564-9. PubMed ID: 26897929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
